The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study

ÖZKOCAMAN V., ÖZKALEMKAŞ F., Seyhan S., ENER B., URSAVAŞ A., Ersal T., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.35, no.4, pp.277-282, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.4274/tjh.2017.0430
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.277-282
  • Keywords: Acute myeloid leukemia, Invasive fungal infections, Antifungal prophylaxis, Posaconazole, BRONCHOALVEOLAR LAVAGE FLUID, INVASIVE FUNGAL-INFECTIONS, ACUTE MYELOGENOUS LEUKEMIA, ASPERGILLOSIS, GALACTOMANNAN, FLUCONAZOLE, GUIDELINES, ITRACONAZOLE, CHEMOTHERAPY, EXPERIENCE
  • Bursa Uludag University Affiliated: Yes

Abstract

Objective: Invasive fungal infections (IFIs) are a significant cause of morbidity and mortality among neutropenic patients undergoing chemotherapy for acute myeloid leukemia (AML) and stem cell transplantation. The aim of this study was to evaluate the real-life impact of posaconazole prophylaxis.